These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2478607)

  • 1. Platelet-activating factor stimulates secretion of respiratory glycoconjugate from human airways in culture.
    Goswami SK; Ohashi M; Stathas P; Marom ZM
    J Allergy Clin Immunol; 1989 Nov; 84(5 Pt 1):726-34. PubMed ID: 2478607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet activating factor and tracheobronchial respiratory glycoconjugate release in feline and human explants: involvement of the lipoxygenase pathway.
    Lundgren JD; Kaliner M; Logun C; Shelhamer JH
    Agents Actions; 1990 Jun; 30(3-4):329-37. PubMed ID: 2117336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of cotton bract extract on respiratory glycoconjugate secretion from human airways in vitro.
    Marom Z; Schachter EN; Goswami S; Witek T; Buck M
    J Allergy Clin Immunol; 1989 Nov; 84(5 Pt 1):710-7. PubMed ID: 2478605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-activating factor provokes release of mucin-like glycoproteins from guinea pig respiratory epithelial cells via a lipoxygenase-dependent mechanism.
    Adler KB; Akley NJ; Glasgow WC
    Am J Respir Cell Mol Biol; 1992 May; 6(5):550-6. PubMed ID: 1316134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-activating factor stimulates eicosanoid production in cultured feline tracheal explants.
    Wu T; Lundgren JD; Rieves RD; Doerfler ME; Logun C; Shelhamer JH
    Exp Lung Res; 1991; 17(6):1079-94. PubMed ID: 1663033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-activating factor increases platelet-dependent glycoconjugate secretion from tracheal submucosal gland.
    Sasaki T; Shimura S; Ikeda K; Sasaki H; Takishima T
    Am J Physiol; 1989 Dec; 257(6 Pt 1):L373-8. PubMed ID: 2692465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythromycin inhibits respiratory glycoconjugate secretion from human airways in vitro.
    Goswami SK; Kivity S; Marom Z
    Am Rev Respir Dis; 1990 Jan; 141(1):72-8. PubMed ID: 2404441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ro 19-3704 directly inhibits immunoglobulin E-dependent mediator release by a mechanism independent of its platelet-activating factor antagonist properties.
    Gilfillan AM; Wiggan GA; Hope WC; Patel BJ; Welton AF
    Eur J Pharmacol; 1990 Feb; 176(3):255-62. PubMed ID: 1691711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Airway epithelial cell mucin release: immunologic quantitation and response to platelet-activating factor.
    Rieves RD; Goff J; Wu T; Larivee P; Logun C; Shelhamer JH
    Am J Respir Cell Mol Biol; 1992 Feb; 6(2):158-67. PubMed ID: 1540379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet activating factor stimulates secretion of mucin by explants of rodent airways in organ culture.
    Adler KB; Schwarz JE; Anderson WH; Welton AF
    Exp Lung Res; 1987; 13(1):25-43. PubMed ID: 3653044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The platelet-independent release of thromboxane A2 by Paf-acether from guinea-pig lungs involves mechanisms distinct from those for leukotriene.
    Lefort J; Rotilio D; Vargaftig BB
    Br J Pharmacol; 1984 Jul; 82(3):565-75. PubMed ID: 6430375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of platelet activating factor-induced bronchoconstriction in humans.
    Smith LJ; Rubin AH; Patterson R
    Am Rev Respir Dis; 1988 May; 137(5):1015-9. PubMed ID: 3195800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of platelet-activating factor on airway vascular permeability: possible mechanisms.
    Evans TW; Chung KF; Rogers DF; Barnes PJ
    J Appl Physiol (1985); 1987 Aug; 63(2):479-84. PubMed ID: 3115939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited interference of specific Paf antagonists with hyper-responsiveness to Paf itself of lungs from actively sensitized guinea-pigs.
    Pretolani M; Lefort J; Vargaftig BB
    Br J Pharmacol; 1989 Jun; 97(2):433-42. PubMed ID: 2474345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoxygenase metabolites mediate increased airways responsiveness to histamine after acute platelet activating factor exposure in the guinea-pig.
    Anderson GP; Fennessy MR
    Agents Actions; 1988 Jun; 24(1-2):8-19. PubMed ID: 2841832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological modulation of platelet activating factor (PAF)-induced bronchoconstriction and hypertension in anaesthetized guinea-pigs.
    Iwama T; Shikada K; Tanaka S
    J Pharm Pharmacol; 1988 Aug; 40(8):544-7. PubMed ID: 2907007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of vasoactive substances released by platelet-activating factor in the rat perfused heart.
    Hu WM; Man RY
    Br J Pharmacol; 1991 Dec; 104(4):933-7. PubMed ID: 1810604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a 5-lipoxygenase inhibitor and leukotriene antagonist (PF 5901) on PAF-induced airway responses in neonatally immunized rabbits.
    Herd CM; Donigi-Gale D; Shoupe TS; Page CP
    Br J Pharmacol; 1992 Dec; 107(4):1108-15. PubMed ID: 1467833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of REV 5901, a 5-lipoxygenase inhibitor and leukotriene antagonist, on pulmonary responses to platelet activating factor in the guinea-pig.
    Anderson G; Fennessy M
    Br J Pharmacol; 1988 Aug; 94(4):1115-22. PubMed ID: 3145088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The alkyl-ether phospholipid platelet-activating factor is a stimulator of the hypothalamic-pituitary-adrenal axis in the rat.
    Bernardini R; Calogero AE; Ehrlich YH; Brucke T; Chrousos GP; Gold PW
    Endocrinology; 1989 Aug; 125(2):1067-73. PubMed ID: 2546734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.